Myopia Control with Stellest 2.0 Lenses: FDA-Approved Glasses for Kids

Myopia Control with Stellest Key Takeaways

  • Myopia is not a benign refractive condition. It is a disease state that requires active management.
  • Myopia control with Stellest offers a simple, spectacle-based solution using HALT technology to slow progression.
  • Doctors should keep communication simple, identify risk early, and leverage their team to support the patient journey.
Dr. Darryl Glover, Optometrist and Podcaster, and Dr. Ryan Parker, Optometrist and Stellest Expert
Dr. Darryl Glover, Optometrist and Podcaster, and Dr. Ryan Parker, Optometrist and Stellest Expert

Myopia Control with Stellest: Why This Matters Now

Myopia control with Stellest is becoming an essential conversation in eye care as more pediatric patients present with progressive myopia. The approach to managing myopia has changed significantly over time. Historically, it was often treated by simply increasing minus power at each visit. Today, there is a much deeper understanding of the condition.

As shared in the discussion, myopia is not just a refractive issue. It is a disease with a refractive component. That distinction is important because it changes how doctors should approach care. Instead of a passive model, there is now a need for active management, consistent follow-up, and intentional patient engagement.

Why Myopia Control Is Essential for Patients

The importance of myopia control comes down to long-term outcomes. As myopia progresses, patients are at higher risk for complications later in life. The conversation highlights that increased levels of myopia are associated with conditions such as:

  • Glaucoma
  • Retinal tears, breaks, and detachments
  • Earlier cataract development

Because of these risks, the management approach must change. Myopia should be treated more like other chronic eye conditions. Patients should not simply receive a prescription and return years later. Instead, they should be:

  • Brought back regularly
  • Monitored for progression
  • Managed with appropriate solutions over time

What Is Myopia Control with Stellest

Myopia control with Stellest provides a solution that is both effective and simple to implement. Stellest lenses are spectacle lenses that incorporate HALT technology, which creates a volume of myopic defocus to slow eye growth and progression.

A key point from the discussion is how straightforward this solution is. It is described as simple, easy to use, and capable of delivering strong distance vision acuity.

This simplicity makes it easier for doctors to introduce myopia management into their practice without overcomplicating workflows or overwhelming patients.

Stellest Lens Parameters

Understanding the parameters is essential when prescribing myopia control with Stellest. From the discussion, the available ranges include:

  • Sphere: Plano to -10.00D
  • Cylinder: Up to -4.00D

Important clarification:

  • The prescription is based on the strongest meridian
  • Total power cannot exceed -10.00D in any meridian

This allows doctors to treat a wide range of pediatric patients within a spectacle-based solution.

How to Identify Patients for Stellest

Myopia control with Stellest begins with identifying which patients are at risk. The discussion highlights key considerations:

  • Age of the patient
  • Refractive status
  • Whether parents are myopic
  • Time spent outdoors

Every child should be evaluated for risk. Once identified, the decision becomes whether to monitor more closely or initiate a myopia control solution.

How to Talk to Patients and Parents

One of the strongest messages from the discussion is to keep communication simple. Doctors are encouraged not to overcomplicate the conversation. The focus should be on:

  • Explaining that myopia can progress
  • Highlighting long-term risks
  • Presenting Stellest as a straightforward solution
  • Keep it simple.

This approach helps patients and parents better understand the importance of treatment and improves acceptance.

The Role of the Team in Myopia Control

Myopia control with Stellest is not solely the doctor’s responsibility. It requires a team-based approach. From the discussion:

  • The doctor identifies risk and prescribes
  • The team supports the patient and helps guide the solution

This improves efficiency in the exam room and ensures consistent communication throughout the patient experience.

The closing message is clear. Now is the time to act. Myopia control with Stellest provides a practical and simple opportunity to improve how pediatric patients are managed. Doctors have the ability to:

  • Take a more proactive approach
  • Improve long-term patient outcomes
  • Strengthen relationships with families

The opportunity is there. The next step is to implement it.

Drs. Glover & Lyerly
Drs. Glover & Lyerlyhttps://defocusmediagroup.com
Defocus Media is run by two successful Millennial optometrists and social media entrepreneurs, Dr. Jennifer Lyerly and Dr. Darryl Glover. They have proven track records of successfully engaging online readers and followers. They reside and practice in North Carolina.

Get in Touch

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.

Related Articles

Latest Posts